Oleanolic acid alleviated pressure overload-induced cardiac remodeling

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2015-07-28

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s11010-015-2520-1PMID 26215454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Never in Mitosis Gene A Related Kinase-6 Attenuates Pressure Overload-Induced Activation of the Protein Kinase B Pathway and Cardiac Hypertrophy

  2014cited by this paper
• The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications.

  2014cited by this paper
• Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.

  2014cited by this paper
• Mammalian target of rapamycin signaling in cardiac physiology and disease.

  2014cited by this paper
• Oleanolic acid inhibits proliferation and invasiveness of Kras-transformed cells via autophagy.

  2014cited by this paper
• Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

  2014cited by this paper
• Targeting cardiac hypertrophy: toward a causal heart failure therapy.

  2014cited by this paper
• Indole-3-carbinol protects against pressure overload induced cardiac remodeling via activating AMPK-α.

  2013cited by this paper
• SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway

  2012cited by this paper
• Targeting the Transcription Factor Nrf2 to Ameliorate Oxidative Stress and Inflammation in Chronic Kidney Disease

  2012cited by this paper
• Oleanolic Acid: A Novel Cardioprotective Agent That Blunts Hyperglycemia-Induced Contractile Dysfunction

  2012cited by this paper
• Curative Effects of Oleanolic Acid on Formed Hypertrophic Scars in the Rabbit Ear Model

  2012cited by this paper
• Molecular basis of physiological heart growth: fundamental concepts and new players

  2012cited by this paper
• Inhibition of IκB phosphorylation prevents load-induced cardiac dysfunction in mice.

  2012cited by this paper
• Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease

  2012cited by this paper
• Oleanolic Acid Prevents Glucocorticoid‐induced Hypertension in Rats

  2011cited by this paper
• The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease.

  2009cited by this paper
• Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure

  2008cited by this paper
• Cardioprotective Effect of Oleanolic Acid on Isoproterenol-Induced Myocardial Ischemia in Rats

  2007cited by this paper
• Increased Connective Tissue Growth Factor Relative to Brain Natriuretic Peptide as a Determinant of Myocardial Fibrosis

  2007cited by this paper
• Triterpenoid saponin, oleanolic acid 3-O-beta-d-glucopyranosyl(1-->3)-alpha-l-rhamnopyranosyl(1-->2)-alpha-l-arabinopyranoside (OA) from Aralia elata inhibits LPS-induced nitric oxide production by down-regulated NF-kappaB in raw 264.7 cells.

  2007cited by this paper
• Triterpenoid saponin, oleanolic acid 3-O-β-d-glucopyranosyl(1 → 3)-α-l-rhamnopyranosyl(1 → 2)-α-l-arabinopyranoside (OA) from Aralia elata inhibits LPS-induced nitric oxide production by down-regulated NF-κB in raw 264.7 cells

  2007cited by this paper
• The role of TGF-β Signaling in Myocardial Infarction and Cardiac Remodeling

  2007cited by this paper
• ECM remodeling in hypertensive heart disease.

  2007cited by this paper
• Glycogen synthase kinase-3beta -- actively inhibiting hypertrophy.

  2007cited by this paper
• The role of TGF-beta signaling in myocardial infarction and cardiac remodeling.

  2007cited by this paper
• Glycogen Synthase Kinase-3β—Actively Inhibiting Hypertrophy

  2007cited by this paper
• Pomegranate Flower Extract Diminishes Cardiac Fibrosis in Zucker Diabetic Fatty Rats: Modulation of Cardiac Endothelin-1 and Nuclear Factor-kappaB Pathways

  2005cited by this paper
• Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo

  2001cited by this paper

• The Effect and Mechanism of Oleanolic Acid in the Treatment of Metabolic Syndrome and Related Cardiovascular Diseases

  2024cites this paper
• Pentacyclic triterpenes, potential novel therapeutic approaches for cardiovascular diseases

  2024cites this paper
• The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice.

  2023cites this paper
• Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents

  2023cites this paper
• Oleanolic acid derivative alleviates cardiac fibrosis through inhibiting PTP1B activity and regulating AMPK/TGF-β/Smads pathway.

  2023cites this paper
• Cardioprotective Effects of Vitex negundo: A Review of Bioactive Extracts and Compounds

  2023cites this paper
• Oleanolic acid regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the TGF‐β1/SMAD signaling pathway

  2023cites this paper
• Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation

  2022cites this paper
• Qi-Tai-Suan, an oleanolic acid derivative, ameliorates ischemic heart failure via suppression of cardiac apoptosis, inflammation and fibrosis.

  2021cites this paper
• Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy

  2021cites this paper
• Resveratrol Inhibits Ischemia-Induced Myocardial Senescence Signals and NLRP3 Inflammasome Activation

  2020cites this paper
• Role of FoxO3a as a negative regulator of the cardiac myofibroblast conversion induced by TGF-β1.

  2020cites this paper
• Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regula

  2020cites this paper
• Combination treatment of perifosine and valsartan showed more efficiency in protecting against pressure overload induced mouse heart failure.

  2020cites this paper
• Antihypertensive activity of oleanolic acid is mediated via downregulation of secretory phospholipase A2 and fatty acid synthase in spontaneously hypertensive rats

  2020cites this paper
• Lycopene protects against pressure overload-induced cardiac hypertrophy by attenuating oxidative stress.

  2019cites this paper
• New applications of oleanolic acid and its derivatives as cardioprotective agents: A review of their therapeutic perspectives.

  2019cites this paper
• Icariside II attenuates cardiac remodeling via AMPKα2/mTORC1 in vivo and in vitro.

  2018cites this paper
• Caffeic acid phenethyl ester attenuates pathological cardiac hypertrophy by regulation of MEK/ERK signaling pathway in vivo and vitro

  2017cites this paper
• Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

  2017cites this paper
• Apigenin alleviates STZ-induced diabetic cardiomyopathy

  2017cites this paper
• Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.

  2017cites this paper
• Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1

  2017cites this paper